|
| Polymer | Antineoplastic agents/action | Cancer | Route of administration | Reference |
|
| MPEG-b-(PCL-ran-PLLA) diblock copolymer (MCL) | 5-Fluorouracil | Melanoma in vivo mice model tumor | Subcutaneously injected drug delivery system | Seo and coworkers [33] |
|
| Hydroxypropyl-β-cyclodextrin supported in in-situ-forming hydrogels with poloxamers 407 and 188 | Curcumin/antioxidant, anti-inflammatory, antiproliferative and antiangiogenic activities | In vitro
melanoma model in cell lines | Transdermal drug delivery system | Sun and coworkers [34] |
|
| Pluronic F127 | Ibuprofen/nonsteroidal anti-inflammatory | In vitro
melanoma model in cell lines | Topical/transdermal drug delivery system | Marques and MacNeil [35] |
|
| Hydrazone cross-linked sericin/dextran | Doxorubicin | In vivo melanoma model in male mice | Subcutaneously injected drug delivery system | Liu and coworkers [36] |
|
| Glycol chitosan benzaldehyde capped poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (GC-OHC-PEO-PPO-PEO-CHO) | Paclitaxel and doxorubicin
(combination therapy) | In vivo melanoma model in male mice | Subcutaneously injected drug delivery system | Zhao and coworkers [37] |
|
| Poly(2-hydroxypropyl acrylate/itaconic acid) (P(HPA/IA)) | Ni(II) complex with oxaprozin/antiproliferative activity | In vitro melanoma cancer cell lines | Topical/transdermal drug delivery system | Babić and Coworkers [38] |
|
| Nanohydrogels (NHs) based on cholesterol-graft-hyaluronic acid | Bovine serum amine oxidase (BSAO) | In vitro melanoma cancer cell lines | Topical drug delivery system | Montanari and coworkers [39] |
|
| Arginate/chitosan | Bovine serum amine oxidase (BSAO) | | Topical drug delivery system | Agostinelli and coworkers [40] |
|
| Pluronic F127 | AuNPs and DOX | In vivo melanoma model in male mouse | Subcutaneously injected drug delivery system/hyperthermia therapy | Li and coworkers [41] |
|
